Lass4

• Background :

  It is thought that Lass4 may be either a bona fide (dihydro)ceramide synthase or a modulator of its activity. When overexpressed in cells is involved in the production of sphingolipids containing different fatty acid donnors (N-linked stearoyl- (C18) or arachidoyl- (C20) ceramides) in a fumonisin B1-independent manner.

• UniProt :

  Q9HA82

• Species Reactivity :

  Human

• Conjugation :

  Unconjugated

• Type :

  Blocking Peptide

• Applications :

  WB

• Field of Research :

  Cell Biology

• Assay Principle :

  For use with Lass4 polyclonal antibodies (Cat. No. X2298P , X2300P).

• Stability :

  See expiration date on vial

• Concentration :

  See vial for Concentration

• Form :

  Synthetic peptide derived from Human Lass4 protein, Provided as solution in phosphate buffered saline with 0,08% sodium azide

• Precautions :

  This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving Humans or animals.

• Shipping Conditions :

  Ambient Temperature, freeze upon arrival

• Storage Conditions :

  Product should be stored at -20ºC; Aliquot to avoid freeze/thaw cycles

• Functional Analysis :

  WB